胎儿积液潜在的先天性淋巴管异常研究
该研究前瞻性纳入2017至2024年间303例有一个或多个胎儿积液的妊娠,进行外显子或基因组测序,其中8例(3%)诊断为常染色体显性淋巴水肿或全身性淋巴管发育不良,4例遗传自生物学父母,携带PIEZO1杂合变异的胎儿围产期结局更有利。
要点
- 303例胎儿积液妊娠中8例(3%)经分子诊断确诊常染色体显性淋巴水肿或全身性淋巴管发育不良。
- 胎儿积液检出孕周从早孕期至晚孕期,4例遗传自生物学父母,其中1例父母无症状、3例父母症状较胎儿轻。
- PIEZO1杂合变异胎儿的围产期结局更有利。
核心结论
- 常染色体显性淋巴水肿和全身性淋巴管发育不良可表现为早孕期至晚孕期的多种胎儿积液,且常遗传自症状较轻的生物学父母,这些数据有助于理解先天性淋巴管异常在宫内的表现并为未来妊娠的再发风险提供参考。
研究设计与样本
- 前瞻性纳入2017至2024年间有一个或多个胎儿积液的妊娠,进行外显子或基因组测序,并回顾记录提取个人及家族史、超声发现和妊娠结局。
- 胎儿积液包括颈项透明层增厚≥3.5 mm、囊性水瘤、胸腔积液、心包积液、腹水和/或皮肤水肿。
主要发现
- 303例有一个或多个胎儿积液的妊娠中,8例(3%)经分子诊断确诊常染色体显性淋巴水肿或全身性淋巴管发育不良。
- 胎儿积液检出孕周从早孕期至晚孕期;4例胎儿从生物学父母遗传到遗传变异,其中1例父母无症状,3例父母症状较其胎儿轻。
- 携带PIEZO1杂合变异的胎儿围产期结局更有利。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We describe a series of pregnancies with autosomal dominant lymphedema and generalized lymphatic dysplasia in the fetus diagnosed with prenatal exome or genome sequencing. We focus on specific syndromes, fetal features, and parental symptoms to deepen our understanding of congenital lymphatic anomalies. METHODS: Pregnancies with one or more fetal effusions were prospectively enrolled from 2017 to 2024 and underwent exome or genome sequencing. Fetal effusions included increased nuchal translucency ≥ 3.5 mm, cystic hygroma, pleural effusion, pericardial effusion, ascites, and/or skin edema. Records were reviewed to extract personal and family history, ultrasound findings, and pregnancy outcomes. RESULTS: Among 303 pregnancies with one or more fetal effusions, eight (3%) had a molecular diagnosis of autosomal dominant lymphedema or generalized lymphatic dysplasia. Gestational age at detection of fetal effusion(s) ranged from the first through third trimesters. Four fetuses inherited the genetic variant(s) from a biological parent. Of these, one parent was asymptomatic, and three had largely milder symptoms than their fetus. Perinatal outcomes were more favorable for fetuses with heterozygous PIEZO1 variants. CONCLUSION: Autosomal dominant lymphedema and generalized lymphatic dysplasia can present with a breadth of fetal effusions from the first through third trimesters and are frequently inherited from a biological parent with less severe symptoms. These data provide a deeper understanding of how congenital lymphatic anomalies manifest in utero and inform expectations about recurrence risk in future pregnancies.
引用
- Vargo SG, Rogerson D, Devine P, et al. Insights Into Congenital Lymphatic Anomalies Underlying Fetal Effusions. Prenat Diagn. 2025. PMID: 41185095. doi:10.1002/pd.70016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。